<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20221026056310N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-11-21</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effectiveness of lavender scent inhalation on fatigue and stress of mothers of premature babies</public_title>
      <acronym></acronym>
      <scientific_title>The effect of inhaling Lavender scent on fatigue and stress of mothers of premature infants admitted to neonatal intensive care unit</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-11-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>72</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/66510</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: First, we put the studied hospitals (Medical Center, Bahrami, Shariati, Valiasr, Yas, Baharlo and Arash hospitals) into two intervention and control groups through lottery. Then, in the mentioned hospitals, based on the entry criteria and exit criteria, we consider a number of mothers of premature babies as the statistical population. In the next step, we assign a unique number to each of the mothers and put the numbers in a bag. Based on the lottery, we draw numbers until we reach the desired sample size in each of the intervention and control groups.</study_design>
      <phase>3</phase>
      <hc_freetext>Stress and fatigue of mothers of premature babies hospitalized in neonatal intensive care unit.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In this study, lavender essential oil (Lavandula angustifolia) produced by Zardband Yasouj Company - Iran, which is prepared from the flowering branches of the plant and contains 45% linalool, will be used. This substance is inhaled by mothers of premature babies through a neck pendant. This neck pendant is placed at a distance of 20 cm from the nose and inhaled with a dose of two drops for 4 weeks every other day for 30 minutes. Intervention 2: Control group: No aromatherapy is performed in the control group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Information about the main outcome can be shared.

When:
3 months after printing the results

To whom:
Researchers working in academic and scientific institutions

Conditions:
Researchers are allowed to use the results of the data for use in future articles.

Where to obtain:
Azita Ghorbani, contact number 0098 9180857399,
 E-mail address: Trasib54@gmail.com, North Kargar St., in front of 16th St., Tehran University of Medical Sciences Girls' Dormitory, Postal code 1439957181

How to obtain:
The applicant can send his request by e-mail. If you wish, the data will be sent to them after 3 days.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Azita Ghorbani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>North Kargar St, in front of 16th St, Koi complex Tehran university of medical sciences</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1439957181</zip>
        <telephone>+98 21 8801 6071</telephone>
        <email>Trasib54@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Azita Ghorbani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>North Kargar St, in front of 16th St, Koi complex Tehran university of medical sciences</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1439957181</zip>
        <telephone>+98 21 8801 6071</telephone>
        <email>Trasib54@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Having a baby in the neonatal intensive care unit
No history of neurological and mental illness
No history of allergies and respiratory disorders
No history of drug use (anti-anxiety, anti-stress and anti-depressant)
willingness to participate in the study
Avoid drinking caffeinated beverages one hour before the intervention (due to the close relationship between insomnia and fatigue).
The age of the baby is between 30 and 37 weeks
Absence of congenital malformation of the baby</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Death of a baby
Creating postpartum depression
The smell of lavender is unpleasant for the mother
Causing allergic reactions such as headache, nausea and other allergic symptoms for the mother</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F54</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Psychological and behavioral factors associated with disorders or diseases classified elsewhere</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In this study, lavender essential oil (Lavandula angustifolia) produced by Zardband Yasouj Company - Iran, which is prepared from the flowering branches of the plant and contains 45% linalool, will be used. This substance is inhaled by mothers of premature babies through a neck pendant. This neck pendant is placed at a distance of 20 cm from the nose and inhaled with a dose of two drops for 4 weeks every other day for 30 minutes.</i_keyword>
      <i_keyword>Control group: No aromatherapy is performed in the control group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Fatigue score in Multidimensional Fatigue Measurement Questionnaire. Timepoint: (before the start of the intervention) and 14 and 28 days after the start of the intervention. Method of measurement: Multidimensional fatigue measurement questionnaire. The Multidimensional Fatigue Measurement Questionnaire is a 20-item self-report tool that provides a deeper and more accurate understanding of a person's fatigue by evaluating 5 dimensions. The multidimensional fatigue measurement questionnaire has 5 areas: general fatigue (4 items), physical fatigue (4 items), mental fatigue (4 items), activity-related fatigue (4 items) and decreased motivation (4 items). In the fatigue questionnaire, people are measured both in the physical dimension and in the mental dimension. The answer range for each question was a 5-point Likert scale ranging from "yes, completely true" to "no, completely false".</prim_outcome>
      <prim_outcome>Stress score in parental stress questionnaire in neonatal special care unit. Timepoint: (before the start of the intervention) and 14 and 28 days after the start of the intervention. Method of measurement: Parental stress questionnaire in neonatal special care unit. The parental stress questionnaire in the neonatal intensive care unit is a 34-item self-report tool that is used to measure parents' perception of stress in the neonatal intensive care unit. In this questionnaire, there are three subscales that include stress related to: 1- the sights and sounds of the neonatal intensive care unit environment (6 items), 2- the appearance and behavior of the baby and the special treatments performed on the baby (17 items). and 3- parents' relationship with the baby and parental roles (11 items). Answers were scored on a 5-point Likert scale with "1" being "no stress" and "5" being "extremely stressful". A higher score in this questionnaire indicates more stress experience.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-09-27</approval_date>
        <contact_name>Working Group/Committee Ethics in Research Faculty of Nursing and Midwifery and Faculty of Rehabilit</contact_name>
        <contact_address>End of Kargar North, in front of Masjid al-Nabi, Koi Complex for Girls of Medical Sciences, Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
